Savara Inc. Terminates Material Definitive Agreement
Ticker: SVRA · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1160308
| Field | Detail |
|---|---|
| Company | Savara Inc (SVRA) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, corporate-action, pharmaceutical
TL;DR
Savara Inc. just terminated a major deal. Big changes ahead?
AI Summary
Savara Inc. announced on March 31, 2025, the termination of a material definitive agreement. The company, formerly known as Mast Therapeutics, Inc., is based in Austin, TX, and operates in the Pharmaceutical Preparations industry.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's strategic direction, financial health, and future operations.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement often signals significant business challenges or strategic shifts that could affect the company's value.
Key Numbers
- 001-32157 — SEC File Number (Identifies the company's filing with the SEC.)
- 84-1318182 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Savara Inc. (company) — Registrant
- Mast Therapeutics, Inc. (company) — Former Company Name
- March 31, 2025 (date) — Date of Report
- Austin, TX (location) — Business Address
- Langhorne, PA (location) — Principal Executive Offices
FAQ
What was the specific material definitive agreement that was terminated?
The filing does not specify the exact agreement that was terminated, only that a material definitive agreement was terminated as of March 31, 2025.
What are the reasons for the termination of this agreement?
The provided text does not disclose the reasons behind the termination of the material definitive agreement.
When did the termination of the agreement become effective?
The termination of the material definitive agreement was reported as of March 31, 2025.
What is Savara Inc.'s primary business?
Savara Inc. operates in the Pharmaceutical Preparations industry, as indicated by its SIC code [2834].
Has Savara Inc. undergone any previous name changes?
Yes, Savara Inc. was formerly known as Mast Therapeutics, Inc. (name change effective March 12, 2013), ADVENTRX PHARMACEUTICALS INC (name change effective June 13, 2003), and BIOKEYS PHARMACEUTICALS INC (name change effective September 28, 2001).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Savara Inc (SVRA).